The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis

Dong Ha Shin, Hyun Min Park, Kyeong Ah Jung, Han Gon Choi, Jung Ae Kim, Dae Duk Kim, Sang Geon Kim, Keon Wook Kang, Sae Kwang Ku, Thomas W Kensler, Mi Kyoung Kwak

Research output: Contribution to journalArticle

Abstract

Epithelial-mesenchymal transition (EMT) is an underlying mechanism of tissue fibrosis, generating myofibroblasts, which serve as the primary source of extracellular matrix production from tissue epithelial cells. Recently, EMT has been implicated in immunosuppressive cyclosporin A (CsA)-induced renal fibrosis. In this study, the potential role of NRF2, which is the master regulator of genes associated with the cellular antioxidant defense system, in CsA-induced EMT renal fibrosis has been investigated. Pretreatment of rat tubular epithelial NRK-52E cells with sulforaphane, an activator of NRF2, could prevent EMT gene changes such as the loss of E-cadherin and the increase in α-smooth muscle actin (α-SMA) expression. Conversely, genetic inhibition of NRF2 in these cells aggravated changes in CsA-induced EMT markers. These in vitro observations could be confirmed in vivo: CsA treatment resulted in severe renal damage and fibrosis with increased expression of α-SMA in NRF2-deficient mice compared to wild-type mice. NRF2-mediated amelioration of CsA-caused EMT changes could be accounted for in part by the regulation of heme oxygenase-1 (HO-1). CsA treatment increased HO-1 expression in an NRF2-dependent manner in NRK cells as well as in murine fibroblasts. Induction of HO-1 by CsA seems to be advantageous in that it counteracts EMT gene changes: specific increase in HO-1 expression caused by cobalt protoporphyrin prevented CsA-mediated α-SMA induction, whereas genetic inhibition of HO-1 by siRNA substantially enhanced α-SMA induction compared to control cells. Collectively, our results suggest that the NRF2-HO-1 system plays a protective role against CsA-induced renal fibrosis by modulating EMT gene changes.

Original languageEnglish (US)
Pages (from-to)1051-1063
Number of pages13
JournalFree Radical Biology and Medicine
Volume48
Issue number8
DOIs
StatePublished - Apr 2010

Fingerprint

Heme Oxygenase-1
Epithelial-Mesenchymal Transition
Cyclosporine
Fibrosis
Kidney
Genes
Tissue
Myofibroblasts
Cadherins
Fibroblasts
Regulator Genes
Immunosuppressive Agents
Small Interfering RNA
Transcriptional Activation
Extracellular Matrix
Smooth Muscle
Muscle
Rats
Actins
Antioxidants

Keywords

  • Antioxidant defense system
  • Cyclosporin A
  • EMT
  • Free radicals
  • HO-1
  • NRF2
  • Oxidative stress
  • Renal fibrosis

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. / Shin, Dong Ha; Park, Hyun Min; Jung, Kyeong Ah; Choi, Han Gon; Kim, Jung Ae; Kim, Dae Duk; Kim, Sang Geon; Kang, Keon Wook; Ku, Sae Kwang; Kensler, Thomas W; Kwak, Mi Kyoung.

In: Free Radical Biology and Medicine, Vol. 48, No. 8, 04.2010, p. 1051-1063.

Research output: Contribution to journalArticle

Shin, Dong Ha ; Park, Hyun Min ; Jung, Kyeong Ah ; Choi, Han Gon ; Kim, Jung Ae ; Kim, Dae Duk ; Kim, Sang Geon ; Kang, Keon Wook ; Ku, Sae Kwang ; Kensler, Thomas W ; Kwak, Mi Kyoung. / The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis. In: Free Radical Biology and Medicine. 2010 ; Vol. 48, No. 8. pp. 1051-1063.
@article{58751959843548acab76af571c812052,
title = "The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis",
abstract = "Epithelial-mesenchymal transition (EMT) is an underlying mechanism of tissue fibrosis, generating myofibroblasts, which serve as the primary source of extracellular matrix production from tissue epithelial cells. Recently, EMT has been implicated in immunosuppressive cyclosporin A (CsA)-induced renal fibrosis. In this study, the potential role of NRF2, which is the master regulator of genes associated with the cellular antioxidant defense system, in CsA-induced EMT renal fibrosis has been investigated. Pretreatment of rat tubular epithelial NRK-52E cells with sulforaphane, an activator of NRF2, could prevent EMT gene changes such as the loss of E-cadherin and the increase in α-smooth muscle actin (α-SMA) expression. Conversely, genetic inhibition of NRF2 in these cells aggravated changes in CsA-induced EMT markers. These in vitro observations could be confirmed in vivo: CsA treatment resulted in severe renal damage and fibrosis with increased expression of α-SMA in NRF2-deficient mice compared to wild-type mice. NRF2-mediated amelioration of CsA-caused EMT changes could be accounted for in part by the regulation of heme oxygenase-1 (HO-1). CsA treatment increased HO-1 expression in an NRF2-dependent manner in NRK cells as well as in murine fibroblasts. Induction of HO-1 by CsA seems to be advantageous in that it counteracts EMT gene changes: specific increase in HO-1 expression caused by cobalt protoporphyrin prevented CsA-mediated α-SMA induction, whereas genetic inhibition of HO-1 by siRNA substantially enhanced α-SMA induction compared to control cells. Collectively, our results suggest that the NRF2-HO-1 system plays a protective role against CsA-induced renal fibrosis by modulating EMT gene changes.",
keywords = "Antioxidant defense system, Cyclosporin A, EMT, Free radicals, HO-1, NRF2, Oxidative stress, Renal fibrosis",
author = "Shin, {Dong Ha} and Park, {Hyun Min} and Jung, {Kyeong Ah} and Choi, {Han Gon} and Kim, {Jung Ae} and Kim, {Dae Duk} and Kim, {Sang Geon} and Kang, {Keon Wook} and Ku, {Sae Kwang} and Kensler, {Thomas W} and Kwak, {Mi Kyoung}",
year = "2010",
month = "4",
doi = "10.1016/j.freeradbiomed.2010.01.021",
language = "English (US)",
volume = "48",
pages = "1051--1063",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis

AU - Shin, Dong Ha

AU - Park, Hyun Min

AU - Jung, Kyeong Ah

AU - Choi, Han Gon

AU - Kim, Jung Ae

AU - Kim, Dae Duk

AU - Kim, Sang Geon

AU - Kang, Keon Wook

AU - Ku, Sae Kwang

AU - Kensler, Thomas W

AU - Kwak, Mi Kyoung

PY - 2010/4

Y1 - 2010/4

N2 - Epithelial-mesenchymal transition (EMT) is an underlying mechanism of tissue fibrosis, generating myofibroblasts, which serve as the primary source of extracellular matrix production from tissue epithelial cells. Recently, EMT has been implicated in immunosuppressive cyclosporin A (CsA)-induced renal fibrosis. In this study, the potential role of NRF2, which is the master regulator of genes associated with the cellular antioxidant defense system, in CsA-induced EMT renal fibrosis has been investigated. Pretreatment of rat tubular epithelial NRK-52E cells with sulforaphane, an activator of NRF2, could prevent EMT gene changes such as the loss of E-cadherin and the increase in α-smooth muscle actin (α-SMA) expression. Conversely, genetic inhibition of NRF2 in these cells aggravated changes in CsA-induced EMT markers. These in vitro observations could be confirmed in vivo: CsA treatment resulted in severe renal damage and fibrosis with increased expression of α-SMA in NRF2-deficient mice compared to wild-type mice. NRF2-mediated amelioration of CsA-caused EMT changes could be accounted for in part by the regulation of heme oxygenase-1 (HO-1). CsA treatment increased HO-1 expression in an NRF2-dependent manner in NRK cells as well as in murine fibroblasts. Induction of HO-1 by CsA seems to be advantageous in that it counteracts EMT gene changes: specific increase in HO-1 expression caused by cobalt protoporphyrin prevented CsA-mediated α-SMA induction, whereas genetic inhibition of HO-1 by siRNA substantially enhanced α-SMA induction compared to control cells. Collectively, our results suggest that the NRF2-HO-1 system plays a protective role against CsA-induced renal fibrosis by modulating EMT gene changes.

AB - Epithelial-mesenchymal transition (EMT) is an underlying mechanism of tissue fibrosis, generating myofibroblasts, which serve as the primary source of extracellular matrix production from tissue epithelial cells. Recently, EMT has been implicated in immunosuppressive cyclosporin A (CsA)-induced renal fibrosis. In this study, the potential role of NRF2, which is the master regulator of genes associated with the cellular antioxidant defense system, in CsA-induced EMT renal fibrosis has been investigated. Pretreatment of rat tubular epithelial NRK-52E cells with sulforaphane, an activator of NRF2, could prevent EMT gene changes such as the loss of E-cadherin and the increase in α-smooth muscle actin (α-SMA) expression. Conversely, genetic inhibition of NRF2 in these cells aggravated changes in CsA-induced EMT markers. These in vitro observations could be confirmed in vivo: CsA treatment resulted in severe renal damage and fibrosis with increased expression of α-SMA in NRF2-deficient mice compared to wild-type mice. NRF2-mediated amelioration of CsA-caused EMT changes could be accounted for in part by the regulation of heme oxygenase-1 (HO-1). CsA treatment increased HO-1 expression in an NRF2-dependent manner in NRK cells as well as in murine fibroblasts. Induction of HO-1 by CsA seems to be advantageous in that it counteracts EMT gene changes: specific increase in HO-1 expression caused by cobalt protoporphyrin prevented CsA-mediated α-SMA induction, whereas genetic inhibition of HO-1 by siRNA substantially enhanced α-SMA induction compared to control cells. Collectively, our results suggest that the NRF2-HO-1 system plays a protective role against CsA-induced renal fibrosis by modulating EMT gene changes.

KW - Antioxidant defense system

KW - Cyclosporin A

KW - EMT

KW - Free radicals

KW - HO-1

KW - NRF2

KW - Oxidative stress

KW - Renal fibrosis

UR - http://www.scopus.com/inward/record.url?scp=77950517594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950517594&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2010.01.021

DO - 10.1016/j.freeradbiomed.2010.01.021

M3 - Article

C2 - 20096777

AN - SCOPUS:77950517594

VL - 48

SP - 1051

EP - 1063

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 8

ER -